TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO

Stacey Robida-Stubbs1, Kira Glover-Cutter, Dudley W Lamming

  • 1Joslin Diabetes Center, Harvard Stem Cell Institute, and Department of Genetics, Harvard Medical School, Boston, MA 02215, USA.

Cell Metabolism
|May 8, 2012
PubMed

Insights

Inhibiting TORC1 in C. elegans activates protective genes via SKN-1/Nrf and DAF-16/FoxO, increasing stress resistance and longevity. Rapamycin extends worm lifespan by impacting TORC1 and TORC2, mediated by SKN-1.

Area of Science:

  • Molecular Biology
  • Gerontology
  • Genetics

Background:

  • The Target of Rapamycin (TOR) kinase, existing as TORC1 and TORC2 complexes, is crucial for cellular growth.
  • TOR signaling is implicated in aging and various diseases, making its role in lifespan regulation a key research area.

Purpose of the Study:

  • To investigate how TOR kinase signaling influences lifespan and stress resistance in C. elegans.
  • To elucidate the roles of transcription factors SKN-1/Nrf and DAF-16/FoxO in mediating TOR's effects on longevity.

Main Methods:

  • Genetic inhibition of TORC1 in Caenorhabditis elegans.
  • Analysis of gene expression changes, stress resistance, and lifespan.
  • Treatment with rapamycin in C. elegans and mice.

Main Results:

  • Genetic inhibition of TORC1 activates SKN-1/Nrf and DAF-16/FoxO, upregulating protective genes and enhancing stress resistance and longevity.
  • SKN-1 exhibits a feedback loop, increasing TORC1 pathway gene expression.
  • Rapamycin treatment in C. elegans and mice induces protective responses; in worms, lifespan extension is dependent on SKN-1 and involves TORC1 and TORC2 inhibition.

Conclusions:

  • Modulation of SKN-1/Nrf and DAF-16/FoxO transcription factors is critical for the impact of TOR signaling on lifespan in vivo.
  • These transcription factors mediate an antagonistic relationship between growth signals regulated by TOR and longevity.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...